市場調査レポート
商品コード
1072736

デジタルバイオマーカーの世界市場 (2022-2028年):システムコンポーネント・タイプ・用途・エンドユーザー・地域・国別

Global Digital Biomarkers Market - A Global and Regional Analysis: Focus on System Component, Type, Application, End User, Regional and Country-Wise Analysis - Analysis and Forecast, 2022-2028

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 313 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
デジタルバイオマーカーの世界市場 (2022-2028年):システムコンポーネント・タイプ・用途・エンドユーザー・地域・国別
出版日: 2022年04月27日
発行: BIS Research Inc.
ページ情報: 英文 313 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデジタルバイオマーカーの市場規模は、2021年の18億830万米ドルから、予測期間中36.06%のCAGRで推移し、2028年には161億7,400万米ドルの規模に成長すると予測されています。

慢性疾患の高い有病率と発生率の増加、デジタルヘルスケアシステムの技術的進歩が市場成長の主要な推進力となっています。また、新型コロナウイルス感染症 (COVID-19) の流行期間中のウェアラブルデバイスにおけるソフトウェアとAIの統合、mHealthアプリケーションの採用の拡大、遠隔医療と遠隔患者モニタリングシステムへの関心の高まりなどの技術的進歩も市場成長に寄与しています。

当レポートでは、世界のデジタルバイオマーカーの市場を調査し、市場概要、市場への各種影響因子の分析、技術情勢、製品ベンチマーキング、ケーススタディ、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 市場

  • 市場の見通し
  • 世界のデジタルバイオマーカー市場の概要
  • 産業の見通し
    • 技術情勢
    • 主要動向
    • 市場機会評価
    • 製品ベンチマーキング
    • 特許分析
    • ケーススタディ:主要な治療分野
  • COVID-19の影響
  • 事業力学
    • 影響分析
    • 事業成長要因
    • 事業上の課題
    • 事業機会

第2章 世界のデジタルバイオマーカー市場 (用途別)

  • 市場機会評価
  • 成長-シェアマトリックス
  • 胃腸疾患
  • 睡眠・運動障害
  • 心臓血管
  • 精神障害 (気分・行動)
  • 慢性疼痛
  • 神経変性疾患
  • 糖尿病
  • 呼吸器疾患
  • その他

第3章 世界のデジタルバイオマーカー市場 (エンドユーザー別)

  • 市場機会評価
  • 成長-シェアマトリックス
  • バイオ医薬品企業
  • 保険者
  • 医療提供者

第4章 世界のデジタルバイオマーカー市場 (システムコンポーネント別)

  • 市場機会評価
  • 市場シェア分析
  • 成長-シェアマトリックス
  • データ収集ツール
    • ウェアラブルデバイス
    • 埋め込み型
    • モバイルアプリケーション
  • データ統合ソフトウェア
    • デジタルバイオマーカーの機会
    • 新たな展開
    • 市場推計・予測

第5章 世界のデジタルバイオマーカー市場 (タイプ別)

  • 市場機会評価
  • 市場シェア分析
  • 成長-シェアマトリックス
  • 臨床試験
  • 臨床設定

第6章 地域

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第7章 市場-企業プロファイル概要・競合ベンチマーキング

  • 競合情勢
  • 企業プロファイル
    • 既存企業
    • スタートアップ
図表

List of Figures

  • Figure 1: Evolution of Digital Health
  • Figure 2: Applications of Digital Biomarkers
  • Figure 3: Global Digital Biomarkers Market, Impact Analysis
  • Figure 4: Global Digital Biomarkers Market Potential , $Million, 2021, 2024, and 2028
  • Figure 5: Global Digital Biomarkers Market (by System Components), $Million, 2021,2024 and 2028
  • Figure 6: Global Digital Biomarkers Market (by End User), $Million, 2019-2028
  • Figure 7: Global Digital Biomarker Market, Key Developments and Strategies, January 2017-December 2021
  • Figure 8: Growth-Share Matrix of the Global Digital Biomarkers Market, 2021-2028
  • Figure 9: Global Digital Biomarkers Market Segmentation
  • Figure 10: Global Digital Biomarkers Market: Research Methodology
  • Figure 11: Primary Research
  • Figure 12: Secondary Research
  • Figure 13: Data Triangulation
  • Figure 14: Global Digital Biomarkers Market Research Process
  • Figure 15: Assumptions and Limitations
  • Figure 16: Global Digital Biomarkers Market, Realistic Growth Scenario, $Million, 2019-2028
  • Figure 17: Global Digital Biomarkers Market, Optimistic Growth Scenario, $Million, 2019-2028
  • Figure 18: Global Digital Biomarkers Market, Pessimistic Growth Scenario, $Million, 2019-2028
  • Figure 19: Digital Biomarkers Ecosystem
  • Figure 20: Workflow of Digital Health Tools
  • Figure 21: Global Digital Biomarkers Market, Short-Term Growth Potential, $Million, 2022-2025
  • Figure 22: Global Digital Biomarkers Market, Long-Term Growth Potential, $Million, 2026-2028
  • Figure 23: Global Digital Biomarkers Market, Product Benchmarking
  • Figure 24: Global Digital Biomarkers Market, Patent Publication Growth Trend, January 2019-December 2021
  • Figure 25: Global Digital Biomarkers Market, Patent Filing Trend (by Country/Cluster), January 2019-December 2021
  • Figure 26: Applications of Wearables in COVID-19
  • Figure 27: Digital Biomarkers and COVID-19 Pandemic
  • Figure 28: Global Digital Biomarkers Market Pre-COVID-19 Scenario, $Million, 2019-2028
  • Figure 29: Global Digital Biomarkers Market Y-o-Y Growth Comparative Analysis (With COVID-19 Vs. Without COVID-19)
  • Figure 30: Impact Trends and Scenarios During COVID-19 (by Region), 2020-2021
  • Figure 31: Global Digital Biomarkers Market, Impact Analysis
  • Figure 32: Process of Transmission of Data in Digital Biomarkers
  • Figure 33: Healthcare Interoperability Challenges
  • Figure 34: Global Digital Biomarkers Market (by Application)
  • Figure 35: Global Digital Biomarkers Market Incremental Opportunity (by Application), $Million, 2022-2028
  • Figure 36: Global Digital Biomarkers Market, Growth-Share Matrix (by Application), 2021-2028
  • Figure 37: Global Digital Biomarkers Market (Gastrointestinal Diseases), $Million, 2019-2028
  • Figure 38: Global Digital Biomarkers Market (Sleep and Movement Disorders), $Million, 2019-2028
  • Figure 39: Global Digital Biomarkers Market (Cardiovascular), $Million, 2019-2028
  • Figure 40: Global Digital Biomarkers Market (Psychiatric Disorders (Mood and Behavior)), $Million, 2019-2028
  • Figure 41: Global Digital Biomarkers Market (Chronic Pain), $Million, 2019-2028
  • Figure 42: Global Digital Biomarkers Market (Neurodegenerative Disorders), $Million, 2019-2028
  • Figure 43: Global Digital Biomarkers Market (Diabetes), $Million, 2019-2028
  • Figure 44: Global Digital Biomarkers Market (Respiratory Diseases), $Million, 2019-2028
  • Figure 45: Global Digital Biomarkers Market (Others), $Million, 2019-2028
  • Figure 46: Global Digital Biomarkers Market (by End User)
  • Figure 47: Global Digital Biomarkers Market Incremental Opportunity (by End User), $Million, 2022-2028
  • Figure 48: Global Digital Biomarkers Market, Growth-Share Matrix (by End User), 2021-2028
  • Figure 49: Global Digital Biomarkers Market (Biopharmaceutical Companies), $Million, 2019-2028
  • Figure 50: Global Digital Biomarkers Market (Payers), $Million, 2019-2028
  • Figure 51: Global Digital Biomarkers Market (Providers), $Million, 2019-2028
  • Figure 52: Global Digital Biomarkers Market (by System Components)
  • Figure 53: Global Digital Biomarkers Market Incremental Opportunity (by System Component), $Million, 2022-2028
  • Figure 54: Market Share Analysis (by System Components), $Million, 2021
  • Figure 55: Global Digital Biomarkers Market, Growth-Share Matrix (by System Components), 2021-2028
  • Figure 56: Global Digital Biomarker Data Collection Tools Market, $Million, 2019-2028
  • Figure 57: Applications of Healthcare Wearables
  • Figure 58: Number of Clinical Trials Using Connected Wearable Devices (by Year) (Cumulative)
  • Figure 59: Global Digital Biomarkers Market (Wearable Devices), $Million, 2019-2028
  • Figure 60: Global Digital Biomarkers Market (Implantables), $Million, 2019-2028
  • Figure 61: Benefits of mHealth
  • Figure 62: Global Digital Biomarkers Market (Mobile Applications), $Million, 2019-2028
  • Figure 63: Process of Data Integration in Remote Patient Monitoring (RPM)
  • Figure 64: Global Digital Biomarkers Market (Data Integration Software), $Million, 2019-2028
  • Figure 65: Global Digital Biomarkers Market (by Type)
  • Figure 66: Global Digital Biomarkers Market Incremental Opportunity (by Type), $Million, 2022-2028
  • Figure 67: Market Share Analysis (by Type), $Million, 2021
  • Figure 68: Global Digital Biomarkers Market, Growth-Share Matrix (by Type), 2021-2028
  • Figure 69: Global Digital Biomarkers Market (Clinical Trials), $Million, 2019-2028
  • Figure 70: Global Digital Biomarkers Market (Clinical Settings), $Million, 2019-2028
  • Figure 71: North America Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028
  • Figure 72: North America Digital Biomarkers Market, $Million, 2019-2028
  • Figure 73: North America Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 74: North America Digital Biomarkers Market (By Type), $Million, 2019-2028
  • Figure 75: U.S. Digital Biomarkers Market, $Million, 2019-2028
  • Figure 76: U.S. Digital Biomarkers Market (by Product Type), $Million, 2019-2028
  • Figure 77: U.S. Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 78: Canada Digital Biomarkers Market, $Million, 2019-2028
  • Figure 79: Canada Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 80: Canada Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 81: Europe Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028
  • Figure 82: Europe Digital Biomarkers Market, $Million, 2019-2028
  • Figure 83: Europe Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 84: Europe Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 85: Netherlands Digital Biomarkers Market, $Million, 2019-2028
  • Figure 86: Netherlands Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 87: Netherlands Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 88: Germany Digital Biomarkers Market, $Million, 2019-2028
  • Figure 89: Germany Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 90: Germany Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 91: France Digital Biomarkers Market, $Million, 2019-2028
  • Figure 92: France Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 93: France Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 94: Italy Digital Biomarkers Market, $Million, 2019-2028
  • Figure 95: Italy Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 96: Italy Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 97: Spain Digital Biomarkers Market, $Million, 2019-2028
  • Figure 98: Spain Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 99: Spain Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 100: Russia Digital Biomarkers Market, $Million, 2019-2028
  • Figure 101: Russia Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 102: Russia Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 103: U.K. Digital Biomarkers Market, $Million, 2019-2028
  • Figure 104: U.K. Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 105: U.K. Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 106: Rest-of-Europe Digital Biomarkers Market, $Million, 2019-2028
  • Figure 107: Rest-of-Europe Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 108: Rest-of-Europe Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 109: Asia-Pacific Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028
  • Figure 110: Asia-Pacific Digital Biomarkers Market, $Million, 2019-2028
  • Figure 111: Asia-Pacific Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 112: Asia-Pacific Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 113: Singapore Digital Biomarkers Market, $Million, 2019-2028
  • Figure 114: Singapore Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 115: Singapore Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 116: Australia Digital Biomarkers Market, $Million, 2019-2028
  • Figure 117: Australia Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 118: Australia Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 119: India Digital Biomarkers Market, $Million, 2019-2028
  • Figure 120: India Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 121: India Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 122: South Korea Digital Biomarkers Market, $Million, 2019-2028
  • Figure 123: South Korea Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 124: South Korea Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 125: Japan Digital Biomarkers market, $Million, 2019-2028
  • Figure 126: Japan Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 127: Japan Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 128: China Digital Biomarkers Market, $Million, 2019-2028
  • Figure 129: China Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 130: China Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 131: Rest-of-Asia-Pacific Digital Biomarkers Market, $Million, 2019-2028
  • Figure 132: Rest-of-Asia-Pacific Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 133: Rest-of-Asia-Pacific Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 134: Latin America Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028
  • Figure 135: Latin America Digital Biomarkers Market, $Million, 2019-2028
  • Figure 136: Latin America Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 137: Latin America Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 138: Brazil Digital Biomarkers Market, $Million, 2019-2028
  • Figure 139: Brazil Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 140: Brazil Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 141: Mexico Digital Biomarkers Market, $Million, 2019-2028
  • Figure 142: Mexico Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 143: Mexico Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 144: Rest-of-Latin America Digital Biomarkers Market, $Million, 2019-2028
  • Figure 145: Rest-of-Latin America Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 146: Rest-of-Latin America Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 147: Rest-of-the-World Digital Biomarkers Market Regulations
  • Figure 148: Rest-of-the-World Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028
  • Figure 149: Rest-of-the-World Digital Biomarkers Market, $Million, 2019-2028
  • Figure 150: Rest-of-the-World Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 151: Rest-of-the-World Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 152: Saudi Arabia Digital Biomarkers Market, $Million, 2019-2028
  • Figure 153: Saudi Arabia Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 154: Saudi Arabia Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 155: U.A.E. Digital Biomarkers Market, $Million, 2019-2028
  • Figure 156: U.A.E. Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 157: U.A.E. Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 158: Israel Digital Biomarkers Market, $Million, 2019-2028
  • Figure 159: Israel Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 160: Israel Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 161: South Africa Digital Biomarkers Market, $Million, 2019-2028
  • Figure 162: South Africa Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 163: South Africa Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 164: Rest-of-Rest-of-the-World Digital Biomarkers Market, $Million, 2019-2028
  • Figure 165: Rest-of-Rest-of-the-World Digital Biomarkers Market (by Type), $Million, 2019-2028
  • Figure 166: Rest-of-Rest-of-the-World Digital Biomarkers Market (by Application), $Million, 2019-2028
  • Figure 167: Global Digital Biomarkers Market, Key Developments, January 2017-February 2022
  • Figure 168: Partnerships, Alliances, and Business Expansions Share (by Company), January 2017-February 2022
  • Figure 169: Funding Activities (by Company), January 2017-February 2022
  • Figure 170: New Product Offerings and Upgradations Share (by Company), January 2017-February 2022
  • Figure 171: Mergers and Acquisitions (by Company), January 2017-February 2022
  • Figure 172: Regulatory and Legal Activities Share (by Company), January 2017-February 2022
  • Figure 173: Alphabet Inc.: Overall Product Portfolio
  • Figure 174: Alphabet Inc.: Overall Financials, $Million, 2019-2021
  • Figure 175: Alphabet Inc.: R&D Expenditure, $Million, 2019-2021
  • Figure 176: Alphabet Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 177: AliveCor, Inc: Overall Product Portfolio
  • Figure 178: Akili Interactive Labs: Overall Product Portfolio
  • Figure 179: Cambridge Cognition Ltd.: Overall Product Portfolio
  • Figure 180: Cambridge Cognition Ltd: Overall Financials, $Million, 2018-2020
  • Figure 181: Cambridge Cognition Ltd: Net Revenue (by Segment), $Million, 2018-2020
  • Figure 182: Cambridge Cognition Ltd: Net Revenue (by Region), $Million, 2018-2020
  • Figure 183: Cambridge Cognition Ltd: R&D Expenditure, $Million, 2018-2020
  • Figure 184: Dassault Systèmes: Overall Product Portfolio
  • Figure 185: Dassault Systèmes: Overall Financials, $Million, 2018-2020
  • Figure 186: Dassault Systèmes: Net Revenue (by Segment), $Million, 2018-2020
  • Figure 187: Dassault Systèmes: Net Revenue (by Region), $Million, 2018-2020
  • Figure 188: Dassault Systèmes: R&D Expenditure, $Million, 2018-2020
  • Figure 189: IXICO plc: Overall Product Portfolio
  • Figure 190: IXICO plc: Overall Financials, $Million, 2019-2021
  • Figure 191: IXICO plc: R&D Expenditure, $Million, 2019-2021
  • Figure 192: IXICO plc: Revenue (by Region), $Million, 2020-2021
  • Figure 193: Koninklijke Philips N.V.: Overall Product Portfolio
  • Figure 194: Koninklijke Philips N.V.: Overall Financials, $Million, 2019-2021
  • Figure 195: Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2019-2021
  • Figure 196: Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2019-2021
  • Figure 197: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2019-2021
  • Figure 198: Shimmer: Overall Product Portfolio
  • Figure 199: Quanterix Corporation: Overall Product Portfolio
  • Figure 200: Quanterix Corporation: Overall Financials, $Million, 2018-2020
  • Figure 201: Quanterix Corporation: Net Revenue (by Segment), $Million, 2018-2020
  • Figure 202: Quanterix Corporation: Net Revenue (by Region), $Million, 2018-2020
  • Figure 203: Quanterix Corporation: R&D Expenditure, $Million, 2018-2020
  • Figure 204: Altoida, AG: Overall Product Portfolio
  • Figure 205: Evidation Health, Inc.: Overall Product Portfolio
  • Figure 206: Happify, Inc.: Overall Product Portfolio
  • Figure 207: Huma: Overall Product Portfolio
  • Figure 208: Human API: Overall Product Portfolio
  • Figure 209: Mindstrong Health: Overall Product Portfolio
  • Figure 210: Neurotrack Technologies, Inc.: Overall Product Portfolio
  • Figure 211: Orikami: Overall Product Portfolio
  • Figure 212: Winterlight Labs, Inc.: Overall Product Portfolio

List of Tables

  • Table 1: Challenges in the Global Digital Biomarkers Market
  • Table 2: Global Digital Biomarkers: Key Trends
  • Table 3: Awaited Technological Developments in the Global Digital Biomarkers Market
  • Table 4: Summary Of Research Studies Performed on Screening, Tracking, and Prevention of COVID-19
  • Table 5: Features of Major Wearable Devices
  • Table 6: Global Digital Biomarkers Market, Major FDA Clearances, 2022
  • Table 7: Commercially Available Mobile Applications Used for Monitoring and Managing Inflammatory Bowel's Disease
  • Table 8: Key Developments in the Gastrointestinal Diseases Space Using Digital Health
  • Table 9: Key Developments in Sleep and Movement Disorders Using Digital Health
  • Table 10: Key Developments in Cardiovascular Diseases Space Using Digital Health
  • Table 11: Key Developments in the Mood-Related Disorders Space Using Digital Health
  • Table 12: Key Developments in Chronic Pain Space Using Digital Health
  • Table 13: Key Developments in Neurodegenerative Disorders Space Using Digital Health
  • Table 14: Key Developments in Diabetes Space Using Digital Health
  • Table 15: Leading Respiratory Conditions and its Incidence (in Million)
  • Table 16: Key Developments in Respiratory Diseases Space Using Digital Health
  • Table 17: Commercial Products Available, Implantable Devices
  • Table 18: North America Digital Biomarkers Market: Regulatory Framework
  • Table 19: North America Digital Biomarkers Market, Impact Analysis
  • Table 20: Europe Digital Biomarkers Market Regulatory Framework
  • Table 21: Challenges in MDR Implementation
  • Table 22: Europe Digital Biomarkers Market, Impact Analysis
  • Table 23: Asia-Pacific Digital Biomarkers Market Regulatory Framework
  • Table 24: Asia-Pacific Digital Biomarkers Market, Impact Analysis
  • Table 25: Latin America Digital Biomarkers Market Regulations
  • Table 26: Latin America Digital Biomarkers Market, Impact Analysis
  • Table 27: Rest-of-the-World Digital Biomarkers Market, Impact Analysis
目次
Product Code: BHD0814SB

“Global Digital Biomarkers Market to Reach $16,174.0 Million by 2028.”

Market Report Coverage - Digital Biomarkers

Market Segmentation

  • System Components - Data Collection Tools (Wearable Devices, Implantables, and Mobile Applications) and Data Integration Software
  • Type - Clinical Trials and Clinical Settings
  • Application - Gastrointestinal Diseases, Sleep and Movement Disorders, Cardiovascular, Psychiatric Disorders (Mood and Behavior), Chronic Pain, Neurodegenerative Diseases, Diabetes, Respiratory Diseases, and Others
  • End User - Biopharmaceutical Companies, Providers, and Payers

Regional Segmentation

  • North America - U.S. and Canada
  • Europe - Germany, U.K., France, Italy, Spain, Russia, Netherlands, and Rest-of-Europe
  • Asia-Pacific - Japan, China, South Korea, India, Australia and Singapore, and Rest-of-Asia-Pacific
  • Latin America - Brazil, Mexico and Rest-of-Latin America
  • Rest-of-the-World - Saudi Arabia, U.A.E, Israel, South Africa and Rest-of-Rest-of-the-World

Market Growth Drivers

  • Rising Popularity of Digital Biomarkers in Drug Development
  • Rising Employment of Vocal Digital Biomarkers
  • Rising Use of Wearable Devices and Increasing Smartphone Penetration
  • Regulatory Flexibility toward Digital Health Solutions
  • Failure of Drugs for Neurodegenerative Disorders

Market Challenges

  • Need for Standardized and Interoperable Solutions
  • Inaccuracy in Data Measurements
  • Lack of Integration and Interoperability between Medical Records and User Generated Data
  • Lack of Use Cases of the Return on Investment (ROI) Analysis

Market Opportunities

  • Digital Biomarkers: The Future of Precision Medicine
  • Early Detection of Neurological Disorders Using Digital Biomarkers
  • Increasing Awareness for General Health Management
  • Upsurge in Demand of Metabolic, Cardiovascular, and Gastrointestinal Healthcare
  • Penetration of Digital Biomarkers in Female, Maternal, Pre- and Neo-Natal Care
  • Rise in Usage of Digital Biomarkers to Assess Pulmonary Health

Key Companies Profiled

Alphabet Inc., AliveCor Inc., Akili Interactive Labs, Inc., Cambridge Cognition Ltd, Dassault Systemes, IXICO plc, Koninklijke Philips N.V., Shimmer, Quanterix Corporation, Altoida AG, Evidation Health, Inc., Happify, Inc., Huma, Human API, Mindstrong Health, Neurotrack Technologies, Inc., Orikami, Winterlight Labs Inc.

How This Report Can Add Value

Assuming that the reader is a manufacturer of digital biomarkers, the report will assist them in the following ways:

  • Understand their position compared to other key players in the market
  • Stay updated with novel technology integration, features, and the latest developments in the market
  • Understand the impact of COVID-19 on digital biomarkers and the entry barriers for new companies
  • Gain insights into end-user perception concerning the digital biomarkers market
  • Identify some key players in the market and understand their valuable contribution

Key Questions Answered in the Report:

  • How has COVID-19 impacted the growth of the global digital biomarkers market?
  • What are the key regulations governing the digital biomarkers market in key regions?
  • What technological developments are projected to have the maximum influence on the global digital biomarkers market?
  • Who are the leading players holding significant dominance in the global digital biomarkers market?
  • What are some of the growth opportunities which market players can capitalize on?
  • What are the drivers and restraints for the global digital biomarkers market?
  • Which region has the highest growth rate in the digital biomarkers market?
  • Which are the fastest growing countries in terms of the global digital biomarkers market?
  • What are the key strategies being adopted by market players in the global digital biomarkers market?

Global Digital Biomarkers Market: Overview

The global digital biomarkers market is projected to witness significant growth during the forecast period 2022-2028. The high prevalence and growing incidences of chronic diseases and the technological advancements in digital healthcare systems are the key propellers for the growth of the market.

During the COVID-19 pandemic, technological advancements such as the integration of software and artificial intelligence (AI) in wearable devices, rising adoption of mHealth applications, and growing interest in telemedicine and remote patient monitoring systems have all contributed to the market growth for digital biomarkers. The global digital biomarkers market report highlights that the market was valued at $1,808.3 million in 2021 and is expected to reach $16,174.0 million by 2028. The market is expected to grow at a CAGR of 36.06% during the forecast period 2022-2028.

Global Digital Biomarkers Market Drivers

Conventional chronic disease diagnostics are very subjective and based on a series of visits. As a result, drug development decisions are based on limited, subjective evidence, resulting in large-scale Phase 3 trials of medications that were unsuccessful. Digital biomarkers can predict the efficacy of a drug more swiftly than a conventional clinical endpoint, thereby accelerating product development in the case of certain therapeutic areas. Moreover, the advancements in digital biomarker technology such as voice-based digital biomarkers, mHealth applications, and the adoption of smart wearable devices are gaining popularity among people.

Furthermore, with the rise in prevalence and incidence of chronic diseases, technological adoption will also increase. As a result, disease diagnosis will become more prevalent, and the global market for digital biomarkers will expand. Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.

Global Digital Biomarkers Market Restraints

The factors restraining the growth of the global digital biomarkers devices market include the risks associated with return on investment (RoI) and the lack of standardized and interoperability solutions. Moreover, people are specifically concerned about the increased risk of medical errors and invasion of patients' privacy when digital health devices are being used instead of conventional methods.

Global Digital Biomarkers Market Opportunities

High growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for digital biomarkers market growth. In an era of machine learning (ML) and artificial intelligence (AI), extracting quantitative digital biomarkers that help in illness detection, characterization, monitoring, and therapy response assessment is becoming increasingly desirable.

Impact of COVID-19 on the Global Digital Biomarkers Market

The COVID-19 pandemic had a debilitating impact on the global healthcare ecosystem. Hospitals and clinics faced several challenges, such as lack of resources, high patient influx, and risk of infection among care providers. The market is projected to witness considerable growth during the forecast period 2022-2028. The increasing innovations and product designs in the global market and the growing use in emerging economies are the driving factors for the market's growth.

Market Segmentation

Global Digital Biomarkers Market (by System Components)

The global digital biomarkers market based on system components product type has been segmented into data collection tools and data integration software. Data collection tools have been further segmented into wearables, implantables, and mobile applications.

Global Digital Biomarkers Market (by Type)

The global digital biomarkers market based on product type has been segmented into clinical trials and clinical settings.

Global Digital Biomarkers Market (by Application)

The global digital biomarkers market, based on application, has been segmented into gastrointestinal diseases, sleep and movement disorders, cardiovascular, psychiatric disorders (mood and behavior), neurodegenerative diseases, diabetes, respiratory diseases, and others.

Global Digital Biomarkers Market (by End User)

The global digital biomarkers market based on end user has been segmented into biopharmaceutical companies, providers, and payers.

Global Digital Biomarkers Market (by Region)

The different regions covered under the global digital biomarkers market include North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

North America is expected to be the most lucrative region for the global digital biomarkers market due to advanced healthcare infrastructure and a high focus on research and development activities. The Asia-Pacific digital biomarkers market is one of the profitable markets with immense potential for expansion by key players in the global digital biomarkers market. The Asia-Pacific digital biomarkers market is expected to grow at the fastest rate during the forecast period. This can be attributed to the massive geriatric population base, which is driving the increase in the volume of digital biomarkers.

Key Market Players and Competition Synopsis

Some key players operating in the market include: AliveCor, Inc., Pear Therapeutics Inc., Abbott, Akili Interactive Labs, Inc., Koninklijke Phillips N.V., Huma, Koneksa Health, Alphabet Inc., and Neurotrack Technologies, Inc.

Some strategies covered in this segment are funding activities, mergers and acquisitions, partnerships, alliances, business expansions, regulatory and legal activities, and new offerings and upgradations.

Table of Contents

1 Markets

  • 1.1 Market Outlook
    • 1.1.1 Product Definition
      • 1.1.1.1 Data Collection Tools
        • 1.1.1.1.1 Wearable Devices
        • 1.1.1.1.2 Implantables
        • 1.1.1.1.3 Mobile Applications
      • 1.1.1.2 Data Integration Software
    • 1.1.2 Inclusion and Exclusion Criteria
    • 1.1.3 Key Findings
    • 1.1.4 Global Market Scenario
      • 1.1.4.1 Realistic Growth Scenario
      • 1.1.4.2 Optimistic Growth Scenario
      • 1.1.4.3 Pessimistic/Conservative Growth Scenario
  • 1.2 Global Digital Biomarkers Market Overview
    • 1.2.1 Current State of Digital Biomarker
    • 1.2.2 Types of Biomarkers
      • 1.2.2.1 Wellness
      • 1.2.2.2 Disease
      • 1.2.2.3 Drugs
    • 1.2.3 Industry
      • 1.2.3.1 Pharmaceutical
      • 1.2.3.2 Biotechnology/Life Sciences
      • 1.2.3.3 Medical Devices
      • 1.2.3.4 Application Vendors
    • 1.2.4 Clinical Trials (Clinical Research Organization)
      • 1.2.4.1 Technology Vendors
    • 1.2.5 Digital Biomarker Ecosystem
      • 1.2.5.1 Wearable Devices
      • 1.2.5.2 Implantable Components/ Sensors
      • 1.2.5.3 Ocular Devices
      • 1.2.5.4 Accelerometers
      • 1.2.5.5 Smart Home Systems/IoTs
      • 1.2.5.6 AR/VR Platforms
      • 1.2.5.7 Desktop/Web Applications
    • 1.2.6 Data Measurement
      • 1.2.6.1 Physiological Parameters
      • 1.2.6.2 Behavioral Parameters
  • 1.3 Industry Outlook
    • 1.3.1 Technology Landscape
      • 1.3.1.1 Artificial Intelligence and Machine Learning
      • 1.3.1.2 Augmented Reality (AR) and Virtual Reality (VR)
      • 1.3.1.3 Blockchain
      • 1.3.1.4 Edge Computing
      • 1.3.1.5 Cloud Computing
    • 1.3.2 Key Trends
    • 1.3.3 Opportunity Assessment
      • 1.3.3.1 Short-Term Growth Potential
      • 1.3.3.2 Long-Term Growth Potential
    • 1.3.4 Product Benchmarking
    • 1.3.5 Patent Analysis
      • 1.3.5.1 Awaited Technological Developments
      • 1.3.5.2 Patent Publication Growth Trend
      • 1.3.5.3 Patent Analysis (by Country/Cluster)
    • 1.3.6 Case Studies: Key Therapeutic Areas
      • 1.3.6.1 Cardiovascular Diseases
      • 1.3.6.2 Parkinson's Diseases
      • 1.3.6.3 Alzheimer's Diseases
  • 1.4 Impact of COVID-19
    • 1.4.1 Impact on Digital Biomarkers
    • 1.4.2 Impact on Device Adoption
    • 1.4.3 Impact on Market Size
      • 1.4.3.1 Pre-COVID-19 Phase
        • 1.4.3.1.1 Global and Regional Analysis
      • 1.4.3.2 During COVID-19 Phase
        • 1.4.3.2.1 Global and Regional Analysis
      • 1.4.3.3 Post-COVID-19 Phase
  • 1.5 Business Dynamics
    • 1.5.1 Impact Analysis
    • 1.5.2 Business Drivers
      • 1.5.2.1 Rising Popularity of Digital Biomarkers in Drug Development
      • 1.5.2.2 Rising Employment of Vocal Digital Biomarkers
      • 1.5.2.3 Rising Use of Wearable Devices and Increasing Smartphone Penetration
      • 1.5.2.4 Regulatory Flexibility toward Digital Health Solutions
      • 1.5.2.5 Failure of Drugs for Neurodegenerative Disorders
    • 1.5.3 Business Challenges
      • 1.5.3.1 Need for Standardized and Interoperable Solutions
      • 1.5.3.2 Inaccuracy in Data Measurements
      • 1.5.3.3 Lack of Integration and Interoperability between Medical Records and User Generated Data
      • 1.5.3.4 Lack of Use Cases of the Return on Investment (ROI) Analysis
    • 1.5.4 Business Opportunities
      • 1.5.4.1 Digital Biomarkers: The Future of Precision Medicine
      • 1.5.4.2 Early Detection of Neurological Disorders Using Digital Biomarkers
      • 1.5.4.3 Increasing Awareness for General Health Management
      • 1.5.4.4 Upsurge in Demand of Metabolic, Cardiovascular, and Gastrointestinal Healthcare
      • 1.5.4.5 Penetration of Digital Biomarkers in Female, Maternal, Pre- and Neo-Natal Care
      • 1.5.4.6 Rise in Usage of Digital Biomarkers to Assess Pulmonary Health

2 Global Digital Biomarker Market (by Application)

  • 2.1 Opportunity Assessment
  • 2.2 Growth-Share Matrix
  • 2.3 Gastrointestinal Diseases
  • 2.4 Sleep and Movement Disorders
  • 2.5 Cardiovascular
  • 2.6 Psychiatric Disorders (Mood and Behavior)
  • 2.7 Chronic Pain
  • 2.8 Neurodegenerative Diseases
  • 2.9 Diabetes
  • 2.1 Respiratory Diseases
  • 2.11 Others

3 Global Digital Biomarkers Market (by End User)

  • 3.1 Opportunity Assessment
  • 3.2 Growth-Share Matrix
  • 3.3 Biopharmaceutical Companies
  • 3.4 Payers
  • 3.5 Providers

4 Global Digital Biomarkers Market (by System Components)

  • 4.1 Opportunity Assessment
  • 4.2 Market Share Analysis
  • 4.3 Growth-Share Matrix
  • 4.4 Data Collection Tools
    • 4.4.1 Wearables Devices
      • 4.4.1.1 Evolution of Wearable Devices in Clinical Trials
      • 4.4.1.2 Wearable Devices in Clinical Trials
      • 4.4.1.3 Actigraphy Devices
      • 4.4.1.4 Opportunity in Digital Biomarker
      • 4.4.1.5 New Developments
      • 4.4.1.6 Market Estimation and Forecast
    • 4.4.2 Implantables
      • 4.4.2.1 Opportunity in Digital Biomarker
      • 4.4.2.2 New Developments
      • 4.4.2.3 Market Estimation and Forecast
    • 4.4.3 Mobile Applications
      • 4.4.3.1 Opportunity in Digital Biomarkers
      • 4.4.3.2 New Developments
      • 4.4.3.3 Market Estimation and Forecast
  • 4.5 Data Integration Software
    • 4.5.1 Opportunity in Digital Biomarker
    • 4.5.2 New Developments
    • 4.5.3 Market Estimation and Forecast

5 Global Digital Biomarkers Market (by Type)

  • 5.1 Opportunity Assessment
  • 5.2 Market Share Analysis
  • 5.3 Growth-Share Matrix
  • 5.4 Clinical Trials
  • 5.5 Clinical Settings

6 Region

  • 6.1 North America Digital Biomarkers Market
    • 6.1.1 Regulatory Framework
    • 6.1.2 Opportunity Assessment
    • 6.1.3 Market Dynamics
      • 6.1.3.1 Impact Analysis
    • 6.1.4 Sizing and Forecast Analysis
      • 6.1.4.1 North America Digital Biomarkers Market (by Application)
      • 6.1.4.2 North America Digital Biomarkers Market (by Type)
    • 6.1.5 North America Digital Biomarkers Market (by Country)
      • 6.1.5.1 U.S.
        • 6.1.5.1.1 Digital Health Scenario
        • 6.1.5.1.2 Degree of Adoption of Wearables
        • 6.1.5.1.3 Degree of Adoption of Mobile Health Applications
        • 6.1.5.1.4 Local Players in the Digital Biomarker Market
        • 6.1.5.1.5 U.S. Digital Biomarkers Market
        • 6.1.5.1.6 U.S. Digital Biomarkers Market (by Type)
        • 6.1.5.1.7 U.S. Digital Biomarkers Market (by Application)
      • 6.1.5.2 Canada
        • 6.1.5.2.1 Digital Health Scenario
        • 6.1.5.2.2 Degree of Adoption of Wearables
        • 6.1.5.2.3 Degree of Adoption of Mobile Health Applications
        • 6.1.5.2.4 Local Players in the Digital Biomarker Market
        • 6.1.5.2.5 Canada Digital Biomarkers Market
        • 6.1.5.2.6 Canada Digital Biomarkers Market (by Type)
        • 6.1.5.2.7 Canada Digital Biomarkers Market (by Application)
  • 6.2 Europe Digital Biomarkers Market
    • 6.2.1 Regulatory Framework
    • 6.2.2 Opportunity Assessment
    • 6.2.3 Market Dynamics
      • 6.2.3.1 Impact Analysis
    • 6.2.4 Sizing and Forecast Analysis
      • 6.2.4.1 Europe Digital Biomarkers Market (by Application)
      • 6.2.4.2 Europe Digital Biomarkers Market (by Type)
    • 6.2.5 Europe Digital Biomarkers Market (by Country)
      • 6.2.5.1 Netherlands
        • 6.2.5.1.1 Digital Health Scenario
        • 6.2.5.1.2 Degree of Adoption of Wearables
        • 6.2.5.1.3 Degree of Adoption of Mobile Health Applications
        • 6.2.5.1.4 Local Players in the Digital Biomarker Market
        • 6.2.5.1.5 Netherlands Digital Biomarkers Market
        • 6.2.5.1.6 Netherlands Digital Biomarkers Market (by Type)
        • 6.2.5.1.7 Netherlands Digital Biomarkers Market (by Application)
      • 6.2.5.2 Germany
        • 6.2.5.2.1 Digital Health Scenario
        • 6.2.5.2.2 Degree of Adoption of Wearables
        • 6.2.5.2.3 Reluctance to Fitness Trackers
        • 6.2.5.2.4 Future of Digital Health in Germany
        • 6.2.5.2.5 Germany Digital Biomarkers Market
        • 6.2.5.2.6 Germany Digital Biomarkers Market (by Type)
        • 6.2.5.2.7 Germany Digital Biomarkers Market (by Application)
      • 6.2.5.3 France
        • 6.2.5.3.1 Digital Health Scenario
        • 6.2.5.3.2 Degree of Adoption of Wearables
        • 6.2.5.3.3 Local Players in Digital Biomarkers Market
        • 6.2.5.3.4 France Digital Biomarkers Market
        • 6.2.5.3.5 France Digital Biomarkers Market (by Type)
        • 6.2.5.3.6 France Digital Biomarkers Market (by Application)
      • 6.2.5.4 Italy
        • 6.2.5.4.1 Digital Health Scenario
        • 6.2.5.4.2 Degree of Adoption of Wearables
        • 6.2.5.4.3 Italy Digital Biomarkers Market
        • 6.2.5.4.4 Italy Digital Biomarkers Market (by Type)
        • 6.2.5.4.5 Italy Digital Biomarkers Market (by Application)
      • 6.2.5.5 Spain
        • 6.2.5.5.1 Digital Health Scenario
        • 6.2.5.5.2 Degree of Adoption of Wearables
        • 6.2.5.5.3 Spain Digital Biomarkers Market
        • 6.2.5.5.4 Spain Digital Biomarkers Market (by Type)
        • 6.2.5.5.5 Spain Digital Biomarkers Market (by Application)
      • 6.2.5.6 Russia
        • 6.2.5.6.1 Digital Health Scenario
        • 6.2.5.6.2 Degree of Adoption of Wearables
        • 6.2.5.6.3 Degree of Adoption of Mobile Health Applications
        • 6.2.5.6.4 Russia Digital Biomarkers Market
        • 6.2.5.6.5 Russia Digital Biomarkers Market (by Type)
        • 6.2.5.6.6 Russia Digital Biomarkers Market (by Application)
      • 6.2.5.7 U.K.
        • 6.2.5.7.1 Digital Health Scenario
        • 6.2.5.7.2 Degree of Adoption of Wearables
        • 6.2.5.7.3 Increasing Sales of Smartwatches
        • 6.2.5.7.4 Abandonment of Wearables
        • 6.2.5.7.5 Local Players in Digital Biomarkers
        • 6.2.5.7.6 U.K. Digital Biomarkers Market
        • 6.2.5.7.7 U.K. Digital Biomarkers Market (by Type)
        • 6.2.5.7.8 U.K. Digital Biomarkers Market (by Application)
      • 6.2.5.8 Rest-of-Europe
        • 6.2.5.8.1 Digital Health Scenario
        • 6.2.5.8.2 Degree of Adoption of Wearables
        • 6.2.5.8.3 Increasing Sales of Smartwatches
        • 6.2.5.8.4 Local Players in Digital Biomarkers
        • 6.2.5.8.5 Rest-of-Europe Digital Biomarkers Market
        • 6.2.5.8.6 Rest-of-Europe Digital Biomarkers Market (by Type)
        • 6.2.5.8.7 Rest-of-Europe Digital Biomarkers Market (by Application)
  • 6.3 Asia-Pacific Digital Biomarkers Market
    • 6.3.1 Regulatory Framework
    • 6.3.2 Opportunity Assessment
    • 6.3.3 Market Dynamics
      • 6.3.3.1 Impact Analysis
    • 6.3.4 Sizing and Forecast Analysis
      • 6.3.4.1 Asia-Pacific Digital Biomarkers Market (by Application)
      • 6.3.4.2 Asia-Pacific Digital Biomarkers Market (by Type)
    • 6.3.5 Asia-Pacific Digital Biomarkers Market (by Country)
      • 6.3.5.1 Singapore
        • 6.3.5.1.1 Digital Health Scenario
        • 6.3.5.1.2 Degree of Adoption of Wearables
        • 6.3.5.1.3 Degree of Adoption of Mobile Health
        • 6.3.5.1.4 Singapore Digital Biomarkers Market
        • 6.3.5.1.5 Singapore Digital Biomarkers Market (by Type)
        • 6.3.5.1.6 Singapore Digital Biomarkers Market (by Application)
      • 6.3.5.2 Australia
        • 6.3.5.2.1 Digital Health Scenario
        • 6.3.5.2.2 Degree of Adoption of Wearables
        • 6.3.5.2.3 Degree of Adoption of Mobile Health
        • 6.3.5.2.4 Australia Digital Biomarkers Market
        • 6.3.5.2.5 Australia Digital Biomarkers Market (by Type)
        • 6.3.5.2.6 Australia Digital Biomarkers Market (by Application)
      • 6.3.5.3 India
        • 6.3.5.3.1 Digital Health Scenario
        • 6.3.5.3.2 Degree of Adoption of Wearables
        • 6.3.5.3.3 Degree of Adoption of Mobile Health
        • 6.3.5.3.4 India Digital Biomarkers Market
        • 6.3.5.3.5 India Digital Biomarkers Market (by Type)
        • 6.3.5.3.6 India Digital Biomarkers Market (by Application)
      • 6.3.5.4 South Korea
        • 6.3.5.4.1 Digital Health Scenario
        • 6.3.5.4.2 Degree of Adoption of Wearables
        • 6.3.5.4.3 Degree of Adoption of Mobile Health
        • 6.3.5.4.4 South Korea Digital Biomarkers Market
        • 6.3.5.4.5 South Korea Digital Biomarkers Market (by Type)
        • 6.3.5.4.6 South Korea Digital Biomarkers Market (by Application)
      • 6.3.5.5 Japan
        • 6.3.5.5.1 Digital Health Scenario
        • 6.3.5.5.2 Degree of Adoption of Wearables
        • 6.3.5.5.3 Degree of Adoption of Mobile Health
        • 6.3.5.5.4 Japan Digital Biomarkers Market
        • 6.3.5.5.5 Japan Digital Biomarkers Market (by Type)
        • 6.3.5.5.6 Japan Digital Biomarkers Market (by Application)
      • 6.3.5.6 China
        • 6.3.5.6.1 Digital Health Scenario
        • 6.3.5.6.2 Degree of Adoption of Wearables
        • 6.3.5.6.3 Degree of Adoption of Mobile Health
        • 6.3.5.6.4 Local Players in Digital Biomarker Market
        • 6.3.5.6.5 China Digital Biomarkers Market
        • 6.3.5.6.6 China Digital Biomarkers Market (by Type)
        • 6.3.5.6.7 China Digital Biomarkers Market (by Application)
      • 6.3.5.7 Rest-of-Asia-Pacific
        • 6.3.5.7.1 Digital Health Scenario
        • 6.3.5.7.2 Degree of Adoption of Wearables
        • 6.3.5.7.3 Degree of Adoption of Mobile Health Applications
        • 6.3.5.7.4 Rest-of-Asia-Pacific Digital Biomarkers Market
        • 6.3.5.7.5 Rest-of-Asia-Pacific Digital Biomarkers Market (by Type)
        • 6.3.5.7.6 Rest-of-Asia-Pacific Digital Biomarkers Market (by Application)
  • 6.4 Latin America Digital Biomarkers Market
    • 6.4.1 Regulatory Framework
    • 6.4.2 Opportunity Assessment
    • 6.4.3 Market Dynamics
      • 6.4.3.1 Impact Analysis
    • 6.4.4 Sizing and Forecast Analysis
      • 6.4.4.1 Latin America Digital Biomarkers Market (by Application)
      • 6.4.4.2 Latin America Digital Biomarkers Market (by Type)
    • 6.4.5 Latin America Digital Biomarkers Market (by Country)
      • 6.4.5.1 Brazil
        • 6.4.5.1.1 Digital Health Scenario
        • 6.4.5.1.2 Degree of Adoption of Mobile Health Applications
        • 6.4.5.1.3 Brazil Digital Biomarkers Market
        • 6.4.5.1.4 Brazil Digital Biomarkers Market (by Type)
        • 6.4.5.1.5 Brazil Digital Biomarkers Market (by Application)
      • 6.4.5.2 Mexico
        • 6.4.5.2.1 Digital Health Scenario
        • 6.4.5.2.2 Degree of Adoption of Mobile Health Applications
        • 6.4.5.2.3 Mexico Digital Biomarkers Market
        • 6.4.5.2.4 Mexico Digital Biomarkers Market (by Type)
        • 6.4.5.2.5 Mexico Digital Biomarkers Market (by Application)
      • 6.4.5.3 Rest-of-Latin America
        • 6.4.5.3.1 Digital Health Scenario
        • 6.4.5.3.2 Degree of Adoption of Wearables
        • 6.4.5.3.3 Degree of Adoption of Mobile Health
        • 6.4.5.3.4 Rest-of-Latin America Digital Biomarkers Market
        • 6.4.5.3.5 Rest-of-Latin America Digital Biomarkers Market (by Type)
        • 6.4.5.3.6 Rest-of-Latin America Digital Biomarkers Market (by Application)
  • 6.5 Rest-of-the-World
    • 6.5.1 Regulatory Framework
    • 6.5.2 Opportunity Assessment
    • 6.5.3 Market Dynamics
      • 6.5.3.1 Impact Analysis
    • 6.5.4 Sizing and Forecast Analysis
      • 6.5.4.1 Rest-of-the-World Digital Biomarkers Market (by Application)
      • 6.5.4.2 Rest-of-the-World Digital Biomarkers Market (by Type)
    • 6.5.5 Rest-of-the-World Digital Biomarkers Market (by Country)
      • 6.5.5.1 Saudi Arabia
        • 6.5.5.1.1 Digital Health Scenario
        • 6.5.5.1.2 Degree of Adoption of Wearables
        • 6.5.5.1.3 Degree of Adoption of Mobile Health Applications
        • 6.5.5.1.4 Saudi Arabia Digital Biomarkers Market
        • 6.5.5.1.5 Saudi Arabia Digital Biomarkers Market (by Type)
        • 6.5.5.1.6 Saudi Arabia Digital Biomarkers Market (by Application)
      • 6.5.5.2 U.A.E
        • 6.5.5.2.1 Digital Health Scenario
        • 6.5.5.2.2 Degree of Adoption of Wearables
        • 6.5.5.2.3 Degree of Adoption of Mobile Health Applications
        • 6.5.5.2.4 U.A.E. Digital Biomarkers Market
        • 6.5.5.2.5 U.A.E. Digital Biomarkers Market (by Type)
        • 6.5.5.2.6 U.A.E. Digital Biomarkers Market (by Application)
      • 6.5.5.3 Israel
        • 6.5.5.3.1 Digital Health Scenario
        • 6.5.5.3.2 Degree of Adoption of Wearables
        • 6.5.5.3.3 Degree of Adoption of Mobile Health Applications
        • 6.5.5.3.4 Israel Digital Biomarkers Market
        • 6.5.5.3.5 Israel Digital Biomarkers Market (by Type)
        • 6.5.5.3.6 Israel Digital Biomarkers Market (by Application)
      • 6.5.5.4 South Africa
        • 6.5.5.4.1 Digital Health Scenario
        • 6.5.5.4.2 Degree of Adoption of Wearables
        • 6.5.5.4.3 Degree of Adoption of Mobile Health Applications
        • 6.5.5.4.4 South Africa Digital Biomarkers Market
        • 6.5.5.4.5 South Africa Digital Biomarkers Market (by Type)
        • 6.5.5.4.6 South Africa Digital Biomarkers Market (by Application)
      • 6.5.5.5 Rest-of-Rest-of-the-World
        • 6.5.5.5.1 Digital Health Scenario
        • 6.5.5.5.2 Degree of Adoption of Wearables
        • 6.5.5.5.3 Degree of Adoption of Mobile Health Applications
        • 6.5.5.5.4 Rest-of-Rest-of -the-World Digital Biomarkers Market
        • 6.5.5.5.5 Rest-of-Rest-of-the-World Digital Biomarkers Market (by Type)
        • 6.5.5.5.6 Rest-of-Rest-of-the-World Digital Biomarkers Market (by Application)

7 Market- Company Profiles and Competitive Benchmarking

  • 7.1 Competitive Landscape
    • 7.1.1 Key Strategies and Developments
      • 7.1.1.1 Partnerships, Alliances, and Business Expansions
      • 7.1.1.2 Funding Activities
        • 7.1.1.2.1 New Offerings
        • 7.1.1.2.2 Mergers and Acquisitions
        • 7.1.1.2.3 Regulatory and Legal Activities
  • 7.2 Company Profiles
    • 7.2.1 Established Companies
      • 7.2.1.1 Alphabet Inc.
        • 7.2.1.1.1 Company Overview
        • 7.2.1.1.2 Role of Alphabet Inc. in the Global Digital Biomarkers Market
        • 7.2.1.1.3 Product Portfolio and Offerings
        • 7.2.1.1.4 Financials
          • 7.2.1.1.4.1 Recent Developments
        • 7.2.1.1.5 SWOT Analysis
      • 7.2.1.2 AliveCor Inc.
        • 7.2.1.2.1 Company Overview
        • 7.2.1.2.2 Role of AliveCor, Inc. in the Global Digital Biomarkers Market
        • 7.2.1.2.3 Product Portfolio and Offerings
        • 7.2.1.2.4 Recent Development
        • 7.2.1.2.5 SWOT Analysis
      • 7.2.1.3 Akili Interactive Labs, Inc.
        • 7.2.1.3.1 Company Overview
        • 7.2.1.3.2 Role of Akili Interactive Labs in the Global Digital Biomarkers Market
        • 7.2.1.3.3 Product Portfolio and Offerings
          • 7.2.1.3.3.1.1 Recent Developments
          • 7.2.1.3.3.1.2 SWOT Analysis
      • 7.2.1.4 Cambridge Cognition Ltd
        • 7.2.1.4.1 Company Overview
        • 7.2.1.4.2 Role of Cambridge Cognition Ltd in the Global Digital Biomarkers Market
        • 7.2.1.4.3 Product Portfolio and Offerings
        • 7.2.1.4.4 Financials
        • 7.2.1.4.5 Recent Developments
        • 7.2.1.4.6 SWOT Analysis
      • 7.2.1.5 Dassault Systemes
        • 7.2.1.5.1 Company Overview
        • 7.2.1.5.2 Role of Dassault Systemes in the Global Digital Biomarkers Market
        • 7.2.1.5.3 Product Portfolio and Offerings
        • 7.2.1.5.4 Financials
        • 7.2.1.5.5 Recent Developments
        • 7.2.1.5.6 SWOT Analysis
      • 7.2.1.6 IXICO plc
        • 7.2.1.6.1 Company Overview
        • 7.2.1.6.2 Role of IXICO plc in the Global Digital Biomarkers Market
        • 7.2.1.6.3 Product Portfolio and Offerings
        • 7.2.1.6.4 Financials
        • 7.2.1.6.5 Recent Developments
        • 7.2.1.6.6 SWOT Analysis
      • 7.2.1.7 Koninklijke Philips N.V.
        • 7.2.1.7.1 Company Overview
        • 7.2.1.7.2 Role of Koninklijke Philips N.V. in the Global Digital Biomarkers Market
        • 7.2.1.7.3 Product Portfolio and Offerings
        • 7.2.1.7.4 Financials
          • 7.2.1.7.4.1 Koninklijke Philips N.V.: SWOT Analysis
      • 7.2.1.8 Shimmer
        • 7.2.1.8.1 Company Overview
        • 7.2.1.8.2 Role of Shimmer in the Global Digital Biomarkers Market
        • 7.2.1.8.3 Product Portfolio and Offerings
          • 7.2.1.8.3.1 Recent Developments
        • 7.2.1.8.4 SWOT Analysis
      • 7.2.1.9 Quanterix Corporation
        • 7.2.1.9.1 Company Overview
        • 7.2.1.9.2 Role of Quanterix Corporation in the Global Digital Biomarkers Market
        • 7.2.1.9.3 Product Portfolio and Offerings
        • 7.2.1.9.4 Financials
        • 7.2.1.9.5 Recent Developments
        • 7.2.1.9.6 SWOT Analysis
    • 7.2.2 Start-Ups
      • 7.2.2.1 Altoida AG
        • 7.2.2.1.1 Company Overview
        • 7.2.2.1.2 Role of Altoida AG in the Global Digital Biomarkers Market
        • 7.2.2.1.3 Product Portfolio and Offerings
        • 7.2.2.1.4 Recent Developments
        • 7.2.2.1.5 SWOT Analysis
      • 7.2.2.2 Evidation Health, Inc.
        • 7.2.2.2.1 Company Overview
        • 7.2.2.2.2 Role of Evidation Health, Inc. in the Global Digital Biomarker Market
        • 7.2.2.2.3 Product Portfolio and Offerings
        • 7.2.2.2.4 Recent Developments
        • 7.2.2.2.5 SWOT Analysis
      • 7.2.2.3 Happify, Inc.
        • 7.2.2.3.1 Company Overview
        • 7.2.2.3.2 Role of Happify, Inc. in the Global Digital Biomarker Market
        • 7.2.2.3.3 Product Portfolio and Offerings
        • 7.2.2.3.4 Recent Developments
        • 7.2.2.3.5 SWOT Analysis
      • 7.2.2.4 Huma
        • 7.2.2.4.1 Company Overview
        • 7.2.2.4.2 Role of Huma in the Global Digital Biomarker Market
        • 7.2.2.4.3 Product Portfolio and Offerings
        • 7.2.2.4.4 Recent Developments
        • 7.2.2.4.5 SWOT Analysis
      • 7.2.2.5 Human API
        • 7.2.2.5.1 Company Overview
        • 7.2.2.5.2 Role of Human API in the Global Digital Biomarkers Market.
        • 7.2.2.5.3 Product Portfolio and Offerings
        • 7.2.2.5.4 Recent Developments
        • 7.2.2.5.5 SWOT Analysis
      • 7.2.2.6 Mindstrong Health
        • 7.2.2.6.1 Company Overview
        • 7.2.2.6.2 Role of Mindstrong Health in the Global Digital Biomarker Market
        • 7.2.2.6.3 Product Portfolio and Offerings
        • 7.2.2.6.4 Recent Developments
        • 7.2.2.6.5 SWOT Analysis
      • 7.2.2.7 Neurotrack Technologies, Inc.
        • 7.2.2.7.1 Company Overview
        • 7.2.2.7.2 Role of Neurotrack Technologies, Inc. in the Global Digital Biomarker Market
        • 7.2.2.7.3 Product Portfolio and Offerings
        • 7.2.2.7.4 Recent Developments
        • 7.2.2.7.5 SWOT Analysis
      • 7.2.2.8 Orikami
        • 7.2.2.8.1 Company Overview
        • 7.2.2.8.2 Role of Orikami in the Global Digital Biomarker Market
        • 7.2.2.8.3 Product Portfolio and Offerings
        • 7.2.2.8.4 Recent Developments
        • 7.2.2.8.5 SWOT Analysis
      • 7.2.2.9 Winterlight Labs Inc.
        • 7.2.2.9.1 Company Overview
        • 7.2.2.9.2 Role of Winterlight Labs, Inc. in the Global Digital Biomarkers Market
        • 7.2.2.9.3 Product Portfolio and Offerings
        • 7.2.2.9.4 Recent Developments
        • 7.2.2.9.5 SWOT Analysis